PXD049409 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | O-GlcNAcylation of RUNX1 promotes its stability and PDGF-BB-mediated resistance to CDK4/6 inhibitors in breast cancer |
Description | Our project was focused on how O-GlyNAcylation of RUNX1 regulates PDGFB expression and Palbociclib-resistance in breast cancer. |
HostingRepository | PRIDE |
AnnounceDate | 2025-01-31 |
AnnouncementXML | Submission_2025-01-31_12:44:37.421.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | YI ZHANG |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-02-15 09:41:20 | ID requested | |
⏵ 1 | 2025-01-31 12:44:37 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: PDGFBB, Palbociclib-resistance,RUNX1 |
Contact List
Dr. Wenge |
contact affiliation | Department of Biochemistry & Molecular Medicine School of Medicine & Health Sciences The George Washington University Washington, DC 20037 |
contact email | wz6812@gwu.edu |
lab head | |
YI ZHANG |
contact affiliation | The George Washington University |
contact email | scholarzy@gwu.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/01/PXD049409 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD049409
- Label: PRIDE project
- Name: O-GlcNAcylation of RUNX1 promotes its stability and PDGF-BB-mediated resistance to CDK4/6 inhibitors in breast cancer